Streetbeat News

Analyst Ratings

GXO

Oppenheimer analyst Scott Schneeberger has maintained an Outperform rating on GXO Logistics (NYSE:GXO) but reduced the price target from $76 to $66.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:32 pm

CTOS

Oppenheimer analyst Scott Schneeberger has maintained an Outperform rating on Custom Truck One Source (NYSE:CTOS) but has reduced the price target from $9 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:30 pm

CALC

Oppenheimer analyst Leland Gershell has reiterated an Outperform rating on CalciMedica (NASDAQ:CALC) and maintained a $14 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:28 pm

TENX

Roth MKM analyst Jonathan Aschoff has reiterated a Buy rating on Tenax Therapeutics (NASDAQ:TENX) and maintained a $6 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:20 pm

NOAH

Noah Holdings' stock has seen an uptick following an upgrade by UBS from Neutral to Buy, accompanied by a price target increase from $16.30 to $18.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:15 pm

NOAH

Noah Holdings' stock has seen an increase in trading after UBS upgraded the company from Neutral to Buy and increased the price target from $16.3 to $18.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:11 pm

PFHC

ProFrac Holding Corp's stock is trading higher following an analyst rating update from Stifel, which maintained a Buy rating and increased the price target from $13 to $14.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:08 pm

YS

Noble Capital Markets has initiated coverage on YS Biopharma Co (NASDAQ:YS) with an Outperform rating and set a price target of $5.25.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:06 pm

HCAT

Health Catalyst (HCAT) stock is trading higher following an upgrade from Neutral to Overweight by Piper Sandler.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:04 pm

GNSS

Roth MKM analyst Scott Searle has initiated coverage on Genasys (NASDAQ:GNSS) with a Buy rating and set a price target of $3.5 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 5:03 pm